SDK Group to produce SPALF Packaging Material for large-scale LIBs

TOKYO, Mar 23, 2020 – (ACN Newswire) – Showa Denko Packaging Co., Ltd. (SPA), a consolidated subsidiary of Showa Denko K.K. (SDK; TSE: 4004), has developed a new product for its SPALF(TM) line of aluminum laminate films for packaging small-scale pouch type lithium-ion batteries (LIBs), and will install equipment to mass produce the new product, for large-scale LIBs and use in electric vehicles (EVs). The new production facility is scheduled for operation in March 2021.

SPALF is a laminated composite film consisting of resins and aluminum foil, mainly used as packaging material for small-scale pouch type LIBs. SPALF enjoys a large global market share due to its superb insulation qualities and plasticity. It is more flexible for molding, more lightweight, and with better heat radiation characteristics than metal, so used as casing for small LIBs in devices such as smartphones and tablets. Recognized for its high quality with safety evaluations progressing, it is increasingly used in large-scale LIB applications, such as EVs. As the EV market is developing in China, following Europe, the Showa Denko Group has decided to install facilities to mass produce SPALF for large-scale LIBs.

The Showa Denko Group's Vision is of becoming a KOSEIHA Company, a group of KOSEIHA Businesses that can maintain profitability and stability at high levels over a long period. The global demand for LIBs (in electrical applications) is expected to increase 30% a year until 2025. The Showa Denko Group produces and sells various LIB materials with distinguishing advantages, such as SPALF(TM), VGCF(TM) additives for anode/cathode materials, and POLYSOL(TM) aqueous binding resin. By increasing sales of these LIB materials, the Group aims to contribute to the growth of the LIB market and the improvement of LIB functionality, and make the Group's LIB materials business grow to become a KOSEIHA Business in the field of advanced battery materials.

About Showa Denko K.K.

Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY), a major manufacturer of chemical products serving heavy industry to electronics and computers. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/ graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit http://www.sdk.co.jp/english/.

Contact:
Showa Denko K.K., Public Relations Office, Tel: 81-3-5470-3235

Showa Denko Group to Mass-produce SPALF Packaging Materials for Large Onboard LIBs

TOKYO, Mar 18, 2020 – (ACN Newswire) – Showa Denko Packaging Co., Ltd. (SPA), a consolidated subsidiary of Showa Denko K.K. (SDK; TSE:4004), has developed a new product to be added to the lineup of SPALF(TM) aluminum laminate films which are used as packaging material for pouch-type lithium-ion batteries (LIBs), and will install equipment to mass-produce the new product. This new product is specialized for large-sized LIBs, which are mainly used for cars. Operation of the new production equipment is scheduled to be started in March, 2021.

SPALF is laminated composite film consisting of resin films and aluminum foil, and is mainly used as packaging material for pouch-type LIBs. SPALF has a large global market share due to its excellent insulation performance and superb plasticity. Pouch-type LIBs have outstanding flexibility in shaping, and are used in many kinds of small devices including smartphones and tablets. Moreover, they are widely used in large-sized equipment including EVs because pouch-type LIBs' high quality has been widely recognized and there has been considerable progress in verification of pouch-type LIBs' safety. Since development of EVs is in progress not only in China but also in Europe and the demand for pouch-type LIBs has been increasing, this time the Showa Denko Group has developed a new type of SPALF for large-sized LIBs and decided to install equipment to mass-produce the new product.

The Showa Denko Group's Vision is to make itself a "KOSEIHA Company" (a group of KOSEIHA Businesses that can maintain profitability and stability at high levels over a long period). The global demand for LIBs (in electrical capacitance) is expected to increase 30% a year until 2025. The Showa Denko Group produces and sells various LIB materials with distinguishing advantages, such as SPALF(TM), VGCF(TM) additives for anode/cathode materials, and POLYSOL(TM) aqueous binding resin. By increasing sales of these LIB materials, the Group will aim to contribute to the growth of LIB market and improvement in functions of LIBs, and make the Group's LIB materials business grow to be established as a KOSEIHA Business in the field of advanced battery materials.

About Showa Denko K.K.

Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY), a major manufacturer of chemical products, serves a wide range of fields from heavy industry to electronics and computer industries. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, and the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory and graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit http://www.sdk.co.jp/english/.

Contact:
Showa Denko K.K., Public Relations Office, Tel: 81-3-5470-3235

Radiologex Partners with Trusona to Bolster User Auth Security for Innovative Healthcare Industry Software

IRVINE, CA, Mar 12, 2020 – (ACN Newswire) – Radiologex announced this week that it has partnered with Trusona, the pioneering leader of passwordless authentication, for its new all-inclusive software for medical doctors, healthcare professionals and healthcare companies. Radiologex(R) or RDEE for short, pronounced [AR-Dee], is the world's first and only one-stop software ecosystem exclusively for the healthcare industry, powered by blockchain technology, and now protected by the highest level of security. The Radiologex product is especially relevant in light of the current novel coronavirus crisis and other health emergencies where the speed, efficiency and confidentiality of communications and data transmission is paramount.

Radiologex is a real-time productivity, collaboration and information resource available via portable device-based app or via the Web. Its advanced user-authentication technology and builtin KYC (Know Your Customer) now includes a state of the art usernameless and passwordless authentication option that was developed by Trusona, the world leader in the field that holds some of the largest financial services and health care companies as clients.

"Compromised credentials are responsible for over 80 percent of breaches. Trusona's mission is to thwart cybercrime by eliminating static credentials from the user experience," said Ori Eisen, Founder and CEO at Trusona. "Radiologex has set the bar high for security within its product and we have integrated our stringent cutting-edge safeguards into their software engine."

"The recent appearance of novel coronavirus, and the very real possibility of a pandemic, is illuminating the need for a one stop instant communications platform dedicated for the healthcare industry, that is also equipped with a full suite of relevant services and productivity enhancing tools, allowing healthcare professionals to carry out various tasks in the most efficient manner when timing is critical. Yet in providing such services, Radiologex does not want to sacrifice security. Secure and safe transmission of information will always remain a top priority for Radiologex," said John Kiyo Smith, CEO, Radiologex.

"Trusona is the only company anywhere in the world that can provide technological solutions that meet our strict standards for security. We are confident our partnership with Trusona will serve to foster trust and peace of mind among Radiologex customers, and is a natural fit with our game changing platform."

Radiologex is the industry's first and only Web 3.0 solution, encompassing productivity tools; clinical information systems; medical imaging processing and storage; entire payment settlement and lending/finance systems; medical supplies, devices and equipment sales and repair services; content on demand; and a dedicated online community. The Radiologex team is comprised of experienced professionals with diverse backgrounds including medical physicians, healthcare service providers (e.g. radiology), and information systems and software developers with blockchain and distributed ledger technology expertise.

"The healthcare industry is highly vulnerable to security breaches and transactional bottlenecks, negatively affecting patient care, including critical care logistics, from start to finish. Radiologex solves for all of that in one easy-to-use platform with safety and speed built in as the vanguard, and partnering with Trusona only serves to enhance these capabilities," says Radiologex Co-founder, George Tyler.

"I headed a study with our team to uncover the primary pain-points experienced by the healthcare industry associated with the SARS epidemic of 2002, which is a scaled-down version of what we are currently experiencing with this COVID-19 event. The primary pain-point we discovered was the unavailability of a streamlined and dedicated communications platform among healthcare providers, which substantially hindered their ability to determine optimal courses of action in a time efficient manner. There was a dearth of communication amongst healthcare providers, large and small, including all levels of government, that was highly uncoordinated, leading to misinformation and contradictory information being disseminated to the public.

"RDEE's messenger module solves for this by offering the only available real-time, dual end encrypted, user KYC'd solution for the entire healthcare industry and even governments, with Trusona technology serving as the gateway for seamless yet ultra-secure access from anywhere. Healthcare professionals will no longer be required to physically be at their respective organizations or login via a cumbersome VPN process on their laptops to establish a wide-ranging communications channel with their colleagues. With Radiologex and Trusona technology, they can now establish unlimited communications channels instantly, from any portable device or web portal, from anywhere in the world, all without remembering a username or password. It will literally be that easy.

"The second major pain-point we discovered was the unfortunate price-gouging of prized medical goods, services, and products essential to containment, which would be subdued by RDEE's Marketplace and Service-on-Demand modules, providing real time global verified product and vendor authenticity, as well as instant, borderless, transactional capacity that can get these goods and services where they need to be with never-before-seen efficiency and swiftness, thanks in no small-part to secure ease of access facilitated by Trusona," added George Tyler.

Trusona (www.trusona.com), founded in 2015 by cybersecurity expert Ori Eisen, is the pioneer and world leader in passwordless authentication. Over 200 organizations, including some of the world's largest financial services and health care companies, rely on Trusona's solutions.

Radiologex (www.radiologex.com) technology is utility patent-pending, tested and certified by the Office of the National Coordinator for Health Information Technology of the U.S. Department of Human and Health Services. The platform is available worldwide with free to use capacities for all users in April 2020.

For more information, contact Drew Saunders at Launch@radiologex.com, Tel (800) 640-2198 or https://radiologex.com. Follow us on Twitter.com@Radiologex and Telegram.com/RadiologexOfficialGroup.

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com